Feed PBE
PB

Invesco Biotechnology & Genome ETF PBE AMEX · Financials · United States

$97.10 -0.80% -$0.78

Summary

Invesco Biotechnology & Genome ETF is an ETF - a fund traded on an exchange like a stock - run by Invesco. Positions inside: 34. The ten largest make up 50% of the fund.

Yearly costs
0.59%
Fund size
$434.3M
Positions
34
Dividend yield
1.38%
Running since
2005

What speaks for it

  • Average yearly growth over the last ten years: 8.5%.
  • It has been running since 2005.

What to watch

  • 100% of the fund is in one sector (Healthcare).
  • 100% of the fund is in one country (United States).
  • Costs of 0.59% a year are above the middle of comparable funds (0.45%).
  • In the last five years its price once dropped by 38% from its high.

A fund has no Bulios Score and no Fair Price of its own - both are computed from the results of a single company. This page shows what is inside the fund and what it costs instead.

Price

Performance

1 month
+1.9%
3 months
+4.4%
This year
+19%
1 year
+26%
3 years
+77%
5 years
+36%
10 years
+127%
Avg. market cap
$53.4B
P/E
27.2x
Forward P/E
21.8x
P/S
4.4x
P/B
4.3x
P/FCF
17.6x
EV/EBITDA
20.7x
Dividend yield
0.34%
ROIC
-15.1%
ROE
48.0%
Gross margin
76.7%
Operating margin
16.2%
Net margin
9.5%
Payout ratio
9.3%
Net debt/EBITDA
2.0x
Beta
0.71

Weighted average of the 30 largest companies, which make up 100% of the fund. Banks and insurers are left out of the gross margin, the ROIC and the EBITDA figures.

What is inside?

Moderately concentrated
  1. 1
    RE
    Regeneron Pharmaceuticals REGN 5.7%
  2. 2
    BI
    Biogen BIIB 5.7%
  3. 3
    GI
    Gilead Sciences GILD 5.7%
  4. 4
    RP
    Royalty Pharma RPRX 5.6%
  5. 5
    AM
    Amgen AMGN 5.3%
  6. 6
    VR
    Vertex Pharmaceuticals VRTX 4.9%
  7. 7
    NT
    Natera NTRA 4.8%
  8. 8
    IL
    Illumina ILMN 4.7%
  9. 9
    MR
    Moderna MRNA 4.0%
  10. 10
    VC
    Vericel VCEL 3.6%

Positions in the fund: 34. The ten largest make up 50% of it.

Composition as of Nov 14, 2026.

Where is it spread?

One sector dominates

By sector

By country

By company size

By the company's market value: Mega cap from $200B, Large cap from $10B, Mid cap from $2B, Small cap from $300M, Micro cap below $300M.

Largest sector: Healthcare (100%). Largest country: United States (100%). Largest size group: Large cap (58%).

What does it cost me?

Expensive
A year from $10,000
$59.00
Over 20 years
$2,828

From every $10,000 invested the fund takes $59.00 a year. You do not pay it separately - it is taken out of the fund's value. Over 20 years at 5% yearly growth that adds up to about $2,828.

How has it done?

Growing over the long run
A year on average, 10 years
+8.5%
Deepest drop
-38%
Yearly volatility
20%

Average yearly growth over the last ten years: 8.5%. Deepest drop in these years: 38% below the earlier high.

Does it pay dividends?

Yes, it pays out
Yield
1.38%
Payments a year
4
Last payment
$0.02

Over the last 12 months it paid $1.33 per share, which is 1.38% of today's price. The last payment was $0.02 on Sep 21, 2026.

Is it easy to buy and sell?

Yes
Traded a day
$2.44M
Shares a day
25K

On an average day about $2.44M of the fund changes hands.

How expensive are the companies inside?

Rather expensive
P/E of the companies inside
27.2
Average Bulios Score
57 out of 100

Weight by Bulios Fair Price

On average the companies inside trade for 27.2 times their yearly profit. By Fair Price, 43% of the rated weight comes out as overvalued.

Counted from its largest companies (30), which make up 100% of the fund. Each company counts by its weight. We use the metrics, the Bulios Score and the Fair Price of the companies themselves.

Similar funds

Funds that hold much of the same. The overlap says how much of their weight they share with this fund.

Fund Domicile Size 1-year change Dividends
FB
FBT First Trust NYSE Arca Biotechnology Index Fund
United States 0.55% $1.69B +36% Pays out 48%
IB
IBB iShares Biotechnology ETF
United States 0.44% $11.0B +29% Pays out 43%
BB
BBH VanEck Biotech ETF
United States 0.35% $534.9M +34% Pays out 43%
20
203780.KS MiraeAsset TIGER NASDAQ BIO ETF
South Korea 0.30% $79.3M +19% Reinvests 41%
IB
IBBQ Invesco Nasdaq Biotechnology ETF
United States 0.19% $84.6M +30% Pays out 41%
SB
SBIO.MI Invesco NASDAQ Biotech UCITS ETF
Ireland 0.40% $651.6M +36% Reinvests 41%

We use essential cookies to run the website and optional analytics cookies to measure usage.

Privacy policy